乳腺癌的预后模型:叙述性审查
1Department of Pathology and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233.
Human pathology
|June 13, 2025
概括
本综述涵盖了临床实践中使用的乳腺癌预后模型. 了解这些模型,这些模型利用临床和病理因素预测患者的结果,对于个性化癌症护理至关重要.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 临床决策 临床决策
背景情况:
- 癌症预后模型使用风险因素估计患者的结果,帮助临床决策.
- 准确预测存活率和复发率是有效患者管理的关键.
- 乳腺癌预后模型在发育,因素,结果和实用性方面有所不同.
研究的目的:
- 审查临床实践中常用的乳腺癌预后模型.
- 突出病理学在评估预后因素中的重要性.
- 强调预后模型在个性化患者护理中的作用.
主要方法:
- 这项研究对现有文献进行了叙事性审查.
- 专注于与乳腺癌相关的预后模型.
- 考虑使用临床和病理参数的模型.
主要成果:
- 存在许多乳腺癌预后模型,在方法和应用上有所不同.
- 病理学评估对于确定预后因素至关重要.
- 模型旨在将患者分为不同风险群体进行分层,以进行量身定制的治疗.
结论:
- 了解乳腺癌预后模型对于病理学家和临床医生来说至关重要.
- 准确的预后评估支持个性化医疗和改善患者结果.
- 持续对模型进行校准和验证,以确保其临床实用性.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162


